{"schema_version":"1","generated_at":"2026-10-30T06:37:36.914Z","data_as_of":null,"url":"https://www.findmykol.com/kol/prantesh-jain","json_url":"https://www.findmykol.com/kol/prantesh-jain/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"prantesh-jain","name":"Prantesh Jain","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Roswell Park Comprehensive Cancer Center","institution_url":"https://www.findmykol.com/institution/roswell-park-comprehensive-cancer-center","city":"Buffalo","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1710295019","orcid":"0000-0003-2771-4612","openalex":"A5060038195"},"summary":"Prantesh Jain is an Oncology physician affiliated with Roswell Park Comprehensive Cancer Center. OpenAlex indexes 87 publications with 1,215 citations (h-index 17); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":87,"cited_by_count":1215,"h_index":17,"latest_activity_year":2025,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06943664","title":"Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer","phase":"PHASE2","status":"NOT_YET_RECRUITING","role":"Overall official","sponsor":"Roswell Park Cancer Institute","source_url":"https://clinicaltrials.gov/study/NCT06943664","trial_url":"https://www.findmykol.com/trial/NCT06943664"},{"nct":"NCT02955290","title":"CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer","phase":"PHASE1/PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"Roswell Park Cancer Institute","source_url":"https://clinicaltrials.gov/study/NCT02955290","trial_url":"https://www.findmykol.com/trial/NCT02955290"}],"source":"trials"},"payments":{"company_count":10,"program_years":{"first":2021,"last":null},"rows_total":11,"shown":3,"withheld":8,"rows":[{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":2000,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1710295019"},{"payer":"Janssen Biotech, Inc.","program_year":2025,"amount_usd":123.85,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1710295019"},{"payer":"Janssen Research & Development, LLC","program_year":2025,"amount_usd":98.08,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1710295019"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1710295019","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Pancancer outcome prediction via a unified weakly supervised deep learning model","year":2025,"journal":"Signal Transduction and Targeted Therapy","source_url":"https://doi.org/10.1038/s41392-025-02374-w","status":"verified"},{"title":"AI-based radiomic features predict outcomes and the added benefit of chemoimmunotherapy over chemotherapy in extensive stage small cell lung cancer: A multi-institutional study","year":2025,"journal":"Cancer Letters","source_url":"https://doi.org/10.1016/j.canlet.2025.217872","status":"verified"},{"title":"2758MO Updated results from a phase I/II study of gocatamig for small cell lung cancer (SCLC) and other neuroendocrine cancers","year":2025,"journal":"Annals of Oncology","source_url":"https://doi.org/10.1016/j.annonc.2025.08.3369","status":"verified"},{"title":"Debio 0123, a highly selective WEE1 inhibitor, in combination with carboplatin (C) and etoposide (E), in patients (pts) with recurrent small cell lung cancer (SCLC): Determination of recommended dose (RD) from a phase 1 escalation.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.8098","status":"verified"},{"title":"NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024","year":2024,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2024.0057","status":"verified"}],"source":"works"},"contact":{"address_1":"ELM AND CARLTON STREETS","city":"Buffalo","state":"NY","zip":"14263","phone":"716-845-2300","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1710295019","source":"identity"},"similar":[{"name":"Igor Puzanov","slug":"igor-puzanov","institution":"Roswell Park Comprehensive Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/igor-puzanov","json_url":"https://www.findmykol.com/kol/igor-puzanov/profile.json"},{"name":"Philip McCarthy","slug":"philip-mccarthy","institution":"Roswell Park Comprehensive Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/philip-mccarthy","json_url":"https://www.findmykol.com/kol/philip-mccarthy/profile.json"},{"name":"Saby George","slug":"saby-george","institution":"Roswell Park Comprehensive Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/saby-george","json_url":"https://www.findmykol.com/kol/saby-george/profile.json"},{"name":"Eunice Wang","slug":"eunice-wang","institution":"Roswell Park Comprehensive Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/eunice-wang","json_url":"https://www.findmykol.com/kol/eunice-wang/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":8,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-06-11","provider_certified":"2021-06-11","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}